Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
9.06
+0.24 (2.72%)
Feb 18, 2026, 4:00 PM EST - Market closed
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $28.8 million as of February 19, 2026. Its market cap has decreased by -18.70% in one year.
Market Cap
28.80M
Enterprise Value
363.11K
1-Year Change
-18.70%
Ranking
Category
Stock Price
$9.06
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $28.80M, a decrease of -96.99%. That is a compound annual growth rate of -44.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 28.80M | -23.22% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 30.11M |
| Reviva Pharmaceuticals Holdings | 29.80M |
| Dyadic International | 29.67M |
| Hyperion DeFi | 29.56M |
| Rein Therapeutics | 29.18M |
| BriaCell Therapeutics | 28.90M |
| NeuroSense Therapeutics | 28.49M |
| AEON Biopharma | 28.34M |